Based on these findings, we hypothesized that Notch signaling molecules (Notch1, DLL1 and Hes1) and Th1-type response factors (T-bet and IFN-γ), along with differences in white blood cell (WBC) parameters may serve as potential biomarkers for predicting disease progression and monitoring therapeutic effect in patients with active TB. This evidence concerns the gene IFNG and tuberculosis.